Pardes Biosciences Inc.

02/08/2022 | Press release | Distributed by Public on 02/08/2022 06:05

Pardes Biosciences to Present Clinical Data from Ongoing PBI-0451 Phase 1 Trial at Conference On Retroviruses And Opportunistic Infections 2022